Rasha M. Abddelgader , Sarvenaz Karamooz , Hosoon Choi , Munok Hwang , Chetan Jinadatha , Dhammika H. Navarathna
{"title":"Skin abscess caused by Trueperella bernardiae: Case report and literature review","authors":"Rasha M. Abddelgader , Sarvenaz Karamooz , Hosoon Choi , Munok Hwang , Chetan Jinadatha , Dhammika H. Navarathna","doi":"10.1016/j.idcr.2024.e01985","DOIUrl":null,"url":null,"abstract":"<div><p>We investigated a skin abscess caused by <em>Trueperella bernardiae</em> in a patient with comorbidities. Initial empirical therapy with Clindamycin did not yield a response, and follow-up culture revealed the presence of <em>T. bernardiae</em> through MALDI-TOF and NGS. Since no CLSI or FDA breakpoints have been published for this strain, resistant gene screening of the genetic sequence showed the presence of the erm(X) gene (with 95 % identity). This gene confers resistance to erythromycin, clindamycin, lincomycin, pristinamycin, quinupristin, and virginiamycin. Subsequent therapy with oral amoxicillin/clavulanate led to complete healing.</p></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214250924000611/pdfft?md5=ef2e8b2146d0e0ecb619af5b3ec71846&pid=1-s2.0-S2214250924000611-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IDCases","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214250924000611","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
We investigated a skin abscess caused by Trueperella bernardiae in a patient with comorbidities. Initial empirical therapy with Clindamycin did not yield a response, and follow-up culture revealed the presence of T. bernardiae through MALDI-TOF and NGS. Since no CLSI or FDA breakpoints have been published for this strain, resistant gene screening of the genetic sequence showed the presence of the erm(X) gene (with 95 % identity). This gene confers resistance to erythromycin, clindamycin, lincomycin, pristinamycin, quinupristin, and virginiamycin. Subsequent therapy with oral amoxicillin/clavulanate led to complete healing.